At first glance, the United States Supreme Court’s 303 Creative LLC. v. Elenis ruling has nothing to do with health care—but, looking deeper, experts in oncology and law are sounding alarms that the decision can be used to discriminate against LGBTQ+ patients.
Progress against cancer, as brought about by high quality academic cancer centers, requires individual excellence from experts who apply distinct, highly specific skill sets to a common goal within the cancer center. The cancer center coordinates and supports these efforts.
Community Outreach and Engagement (COE), now augmented with the Plan to Enhance Diversity (PED), is critical and central to the impact of NCI-designated cancer centers, and both are set forth as required components for the NCI Cancer Center Support Grant (CCSG).
People experiencing racial discrimination are more reluctant to get vaccinations, according to a study conducted by researchers at the University of Arkansas for Medical Sciences Office of Community Health & Research.
A commentary published in the Journal of the National Cancer Institute addresses the issue of cancer equity for people who have been impacted by mass incarceration.
Ishwaria Subbiah was named executive director of cancer care equity and professional wellness at Sarah Cannon Research Institute. In this role, Subbiah will focus on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over 1,300 physicians at over 250 locations in 24 states across the U.S.
Cancer prevention and control and efforts to ensure health equity are essential in meeting the Cancer Moonshot goal of halving cancer mortality in the next 25 years, but some complex scientific and societal problems must be resolved for this to happen, a group of four directors of NCI-designated cancer centers said.
The United States has the worst health outcomes of any high-income nation—lagging behind on health status indicators including mortality, fertility, and morbidity—and recent rulings by Texas district judges against preventive services and mifepristone would widen that gap, experts say.
Francisco Sanchez-Vega was awarded the Corning-MSK Health Equity Research Fellowship, a two-year grant that funds research into the broad disparities in cancer outcomes for patients in historically underserved communities.
The American Cancer Society and Genentech, a member of the Roche Group, are partnering to execute a $4 million collaborative effort to provide equitable access to every cancer patient and their families.
